WA
RPTP

WFG Advisors’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

WFG Advisors’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-145
Closed -$1K – 1772
2015
Q3 		$1K Sell
145
-550
-79% -$6.74K ﹤0.01% 1588
2015
Q2 		$11K Buy
695
+175
+34% +$2.13K ﹤0.01% 1177
2015
Q1 		$6K Hold
520
– – ﹤0.01% 1349
2014
Q4 		$5K Buy
520
+50
+11% +$489 ﹤0.01% 1678
2014
Q3 		$5K Hold
470
– – ﹤0.01% 1700
2014
Q2 		$5K Buy
470
+375
+395% +$3.42K ﹤0.01% 1685
2014
Q1 		$1K Sell
95
-5
-5% -$72 ﹤0.01% 1967
2013
Q4 		$1K Buy
+100
New +$1.38K ﹤0.01% 2204

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WFG Advisors's RPTP Position: Q4 2015 in Review

WFG Advisors sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2015, closing a stake of 145 shares — an estimated $1K sold.

WFG Advisors first reported a position in RPTP in Q4 2013 and held it in 8 quarters. The position peaked at $11K in Q2 2015. 108 funds tracked by Wall St. Rank hold RPTP as of Q4 2015.

  • WFG Advisors reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • WFG Advisors sold 145 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2015, an estimated $1K.
  • WFG Advisors first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 8 quarters.
  • WFG Advisors's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $11K in Q2 2015.
  • 108 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2015.

Based on WFG Advisors's 13F filing for Q4 2015, filed 9 Feb 2016.